By Christian Moess Laursen GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an.
To avoid Medicaid penalties, Glaxo and other drugmakers lowered prices. For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.
By Ian Walker GSK has entered into an exclusive license agreement with Hansoh Pharmaceutical Group for its HS-20093 antibody-drug cancer treatment, with.
By Christian Moess Laursen GSK said it has received a positive opinion recommending the approval of its blood-cancer treatment momelotinib from the European.